Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma

Publisher： Karger

E-ISSN： 1423-0232|71|5-6|341-346

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.5-6, 2007-09, pp. : 341-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 330-338

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 308-315

Karger

Access to resources Recommend Favorite

MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 78, Iss. 1, 2008-09 ,pp. : 49-55

Karger

Access to resources Recommend Favorite

Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-11 ,pp. : 220-228

Karger

Access to resources Recommend Favorite

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 382-390

Karger

Access to resources Recommend Favorite